UniProt ID | HCD2_HUMAN | |
---|---|---|
UniProt AC | Q99714 | |
Protein Name | 3-hydroxyacyl-CoA dehydrogenase type-2 | |
Gene Name | HSD17B10 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 261 | |
Subcellular Localization | Mitochondrion . | |
Protein Description | Mitochondrial dehydrogenase that catalyzes the beta-oxidation at position 17 of androgens and estrogens and has 3-alpha-hydroxysteroid dehydrogenase activity with androsterone. [PubMed: 9553139] | |
Protein Sequence | MAAACRSVKGLVAVITGGASGLGLATAERLVGQGASAVLLDLPNSGGEAQAKKLGNNCVFAPADVTSEKDVQTALALAKGKFGRVDVAVNCAGIAVASKTYNLKKGQTHTLEDFQRVLDVNLMGTFNVIRLVAGEMGQNEPDQGGQRGVIINTASVAAFEGQVGQAAYSASKGGIVGMTLPIARDLAPIGIRVMTIAPGLFGTPLLTSLPEKVCNFLASQVPFPSRLGDPAEYAHLVQAIIENPFLNGEVIRLDGAIRMQP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAACRSVK ------CHHHHHHCC | 12.08 | 25944712 | |
9 | Ubiquitination | AAACRSVKGLVAVIT HHHHHHCCCEEEEEE | 48.01 | - | |
9 | 2-Hydroxyisobutyrylation | AAACRSVKGLVAVIT HHHHHHCCCEEEEEE | 48.01 | - | |
16 | Phosphorylation | KGLVAVITGGASGLG CCEEEEEECCCCHHH | 23.98 | 23828894 | |
20 | Phosphorylation | AVITGGASGLGLATA EEEECCCCHHHHHHH | 37.51 | 27251275 | |
36 | Phosphorylation | RLVGQGASAVLLDLP HHHCCCCCEEEEECC | 26.24 | 21712546 | |
45 | Phosphorylation | VLLDLPNSGGEAQAK EEEECCCCCCHHHHH | 46.35 | 20886841 | |
52 | Ubiquitination | SGGEAQAKKLGNNCV CCCHHHHHHHCCCCE | 36.13 | - | |
52 (in isoform 2) | Ubiquitination | - | 36.13 | 21890473 | |
52 | 2-Hydroxyisobutyrylation | SGGEAQAKKLGNNCV CCCHHHHHHHCCCCE | 36.13 | - | |
52 | Acetylation | SGGEAQAKKLGNNCV CCCHHHHHHHCCCCE | 36.13 | 25953088 | |
52 (in isoform 1) | Ubiquitination | - | 36.13 | 21890473 | |
52 | Malonylation | SGGEAQAKKLGNNCV CCCHHHHHHHCCCCE | 36.13 | 26320211 | |
52 | Ubiquitination | SGGEAQAKKLGNNCV CCCHHHHHHHCCCCE | 36.13 | 21890473 | |
53 | Acetylation | GGEAQAKKLGNNCVF CCHHHHHHHCCCCEE | 65.72 | 25953088 | |
53 | Malonylation | GGEAQAKKLGNNCVF CCHHHHHHHCCCCEE | 65.72 | 26320211 | |
53 | Succinylation | GGEAQAKKLGNNCVF CCHHHHHHHCCCCEE | 65.72 | - | |
53 | Ubiquitination | GGEAQAKKLGNNCVF CCHHHHHHHCCCCEE | 65.72 | - | |
53 | Succinylation | GGEAQAKKLGNNCVF CCHHHHHHHCCCCEE | 65.72 | - | |
58 | Glutathionylation | AKKLGNNCVFAPADV HHHHCCCCEEECCCC | 2.86 | 22555962 | |
66 | Phosphorylation | VFAPADVTSEKDVQT EEECCCCCCHHHHHH | 31.54 | 25627689 | |
67 | Phosphorylation | FAPADVTSEKDVQTA EECCCCCCHHHHHHH | 42.36 | 21815630 | |
69 | 2-Hydroxyisobutyrylation | PADVTSEKDVQTALA CCCCCCHHHHHHHHH | 64.07 | - | |
69 | Acetylation | PADVTSEKDVQTALA CCCCCCHHHHHHHHH | 64.07 | 25953088 | |
69 | Ubiquitination | PADVTSEKDVQTALA CCCCCCHHHHHHHHH | 64.07 | - | |
79 | Ubiquitination | QTALALAKGKFGRVD HHHHHHHCCCCCCCE | 64.58 | 21890473 | |
79 | 2-Hydroxyisobutyrylation | QTALALAKGKFGRVD HHHHHHHCCCCCCCE | 64.58 | - | |
79 (in isoform 1) | Ubiquitination | - | 64.58 | 21890473 | |
79 (in isoform 2) | Ubiquitination | - | 64.58 | 21890473 | |
79 | Acetylation | QTALALAKGKFGRVD HHHHHHHCCCCCCCE | 64.58 | 25038526 | |
79 | Ubiquitination | QTALALAKGKFGRVD HHHHHHHCCCCCCCE | 64.58 | 21906983 | |
91 | Glutathionylation | RVDVAVNCAGIAVAS CCEEEEECCCEEEEE | 2.70 | 22555962 | |
99 (in isoform 2) | Ubiquitination | - | 45.34 | 21890473 | |
99 (in isoform 1) | Ubiquitination | - | 45.34 | 21890473 | |
99 | Acetylation | AGIAVASKTYNLKKG CCEEEEECEEECCCC | 45.34 | 25953088 | |
99 | Ubiquitination | AGIAVASKTYNLKKG CCEEEEECEEECCCC | 45.34 | 21890473 | |
99 | Ubiquitination | AGIAVASKTYNLKKG CCEEEEECEEECCCC | 45.34 | 21890473 | |
99 | Malonylation | AGIAVASKTYNLKKG CCEEEEECEEECCCC | 45.34 | 26320211 | |
105 | Ubiquitination | SKTYNLKKGQTHTLE ECEEECCCCCEEEHH | 60.46 | - | |
105 | Succinylation | SKTYNLKKGQTHTLE ECEEECCCCCEEEHH | 60.46 | 27452117 | |
105 | Acetylation | SKTYNLKKGQTHTLE ECEEECCCCCEEEHH | 60.46 | 26051181 | |
105 | Malonylation | SKTYNLKKGQTHTLE ECEEECCCCCEEEHH | 60.46 | 26320211 | |
125 | Phosphorylation | LDVNLMGTFNVIRLV HCHHCCHHHHHHHHH | 9.70 | 20068231 | |
136 | Sulfoxidation | IRLVAGEMGQNEPDQ HHHHHCCCCCCCCCC | 7.00 | 21406390 | |
153 | Phosphorylation | QRGVIINTASVAAFE CCCEEEEHHHHHCEE | 15.20 | 18452278 | |
153 (in isoform 2) | Phosphorylation | - | 15.20 | - | |
179 | Phosphorylation | KGGIVGMTLPIARDL CCCEEEEEECCHHHC | 24.37 | 21406692 | |
194 | Sulfoxidation | APIGIRVMTIAPGLF CCCCEEEEEECCCCC | 1.29 | 28183972 | |
195 | Phosphorylation | PIGIRVMTIAPGLFG CCCEEEEEECCCCCC | 15.89 | 27542207 | |
203 | Phosphorylation | IAPGLFGTPLLTSLP ECCCCCCCHHHHCCC | 11.93 | 27251275 | |
207 | Phosphorylation | LFGTPLLTSLPEKVC CCCCHHHHCCCHHHH | 35.58 | 27251275 | |
208 | Phosphorylation | FGTPLLTSLPEKVCN CCCHHHHCCCHHHHH | 41.73 | 27542207 | |
212 | Acetylation | LLTSLPEKVCNFLAS HHHCCCHHHHHHHHH | 50.58 | - | |
212 | Succinylation | LLTSLPEKVCNFLAS HHHCCCHHHHHHHHH | 50.58 | - | |
212 | Succinylation | LLTSLPEKVCNFLAS HHHCCCHHHHHHHHH | 50.58 | - | |
214 | S-nitrosylation | TSLPEKVCNFLASQV HCCCHHHHHHHHHCC | 4.40 | 19483679 | |
214 | S-nitrosocysteine | TSLPEKVCNFLASQV HCCCHHHHHHHHHCC | 4.40 | - | |
219 | Phosphorylation | KVCNFLASQVPFPSR HHHHHHHHCCCCCHH | 33.58 | 21712546 | |
258 | Methylation | IRLDGAIRMQP---- EEECCCEECCC---- | 19.70 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HCD2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HCD2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
300438 | 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency (MHBD deficiency) | |||||
300220 | Mental retardation, X-linked, syndromic, 10 (MRXS10) | |||||
300705 | Mental retardation, X-linked 17 (MRX17) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. |